How much funding has Royalty Pharma raised?

Royalty Pharma has raised $60.0M in total funding, most recently a Venture Round.

Who are Royalty Pharma's investors?

Royalty Pharma's investors include Pablo Legorreta.

When was Royalty Pharma founded?

Royalty Pharma was founded in 1996.

Where is Royalty Pharma headquartered?

Royalty Pharma is headquartered in New York, United States.

What industry is Royalty Pharma in?

Royalty Pharma operates in Healthcare, Life Sciences.

Royalty Pharma

IPO

Public · New York, United States · Founded 1996 · $60.0M raised

Healthcare

Life Sciences

Headquarters: New York
Founded: 1996
Business Model: B2B
Website: royaltypharma.com

Total Funding: $60.0M
Last Round: $60.0M Venture RoundJan 1996
Rounds: 1
Type: Public

About

Royalty Pharma, founded in 1996 by Pablo Legorreta, is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry. The company acquires royalty interests in approved and development-stage therapies, partnering with academic institutions, research hospitals, and biotechnology and pharmaceutical companies to fund the discovery and development of new medicines in exchange for a share of future product royalties.

Summary

Royalty Pharma is a Healthcare company based in New York, United States, founded in 1996. It has raised $60.0M in total across 1 round, most recently a $60.0M Venture Round round in Jan 1996. Investors include Pablo Legorreta.